BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37416142)

  • 1. Retracted: Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9781420. PubMed ID: 37416142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
    Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
    Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: lncRNA MSC-AS1/miRNA-429 Axis Mediates Growth and Metastasis of Nasopharyngeal Carcinoma via JAK1/STAT3 Signaling Pathway.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9768312. PubMed ID: 38077908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Circular RNA SMARCA5 Modulates Epithelial-Mesenchymal Transformation, Proliferation, and Metastasis of Nasopharyngeal Carcinoma Cells via microRNA-582-3p/Phosphatase and Tensin Homolog Axis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9876258. PubMed ID: 38125158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9836790. PubMed ID: 38074350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Effects of Cisplatin Combined with Metformin on Proliferation and Apoptosis of Nasopharyngeal Carcinoma Cells.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9856726. PubMed ID: 37475936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Efficacy of Cetuximab in Nasopharyngeal Carcinoma Patients Receiving Concurrent Cisplatin-Radiotherapy: A Meta-Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9798503. PubMed ID: 37416222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9804984. PubMed ID: 37416199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Prediction of Changes in Tumor Regression during Radiotherapy for Nasopharyngeal Carcinoma by Using the Computed Tomography-Based Radiomics.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9809608. PubMed ID: 37547642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Analysis of the Molecular Mechanism of
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9864290. PubMed ID: 37476805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Demographics and Economic Burden of Nasopharyngeal Carcinoma Inpatients.
    International BR
    Biomed Res Int; 2023; 2023():9850320. PubMed ID: 38188831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors.
    Neuroscience CIA
    Comput Intell Neurosci; 2022; 2022():9854614. PubMed ID: 36601276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: USP21 Promotes the Progression of Nasopharyngeal Carcinoma by Regulating FOXM1.
    International SC
    Stem Cells Int; 2024; 2024():9763687. PubMed ID: 38298234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9829630. PubMed ID: 37946834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Application of Artificial Intelligence in Radiotherapy of Nasopharyngeal Carcinoma with Magnetic Resonance Imaging.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9825710. PubMed ID: 38094840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Downregulation of SHCBP1 Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9812746. PubMed ID: 37387977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Relationship between miR-338-3p and Clinicopathological Parameters, Prognosis, and STAT3 mRNA Expression in Nasopharyngeal Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9843805. PubMed ID: 37388095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Effect of Body Size Change on Off-Center Cervical Point and Face Doses in Patients Undergoing Nasopharyngeal Carcinoma Radiotherapy.
    Markers D
    Dis Markers; 2023; 2023():9836583. PubMed ID: 37502571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retracted] miR‑639 is associated with advanced cancer stages and promotes proliferation and migration of nasopharyngeal carcinoma.
    Wang YH; Yin YW; Zhou H; Cao YD
    Oncol Lett; 2024 Feb; 27(2):76. PubMed ID: 38192678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.